Clinical Trial Update: CfDNA in Hereditary And High-risk Malignancies 2

View source ↗

Summary

A clinical trial update on the use of circulating free DNA (cfDNA) in hereditary and high-risk malignancies; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Cancer Syndrome

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hereditary Cancer Syndrome | Status: RECRUITING